Inventor · disambiguated record
Johannes Pohlner
Also filed as: POHLNER JOHANNES
7 granted patents·38 pending applications·82 citations·filing 1987–2024
83Inventor score
Files withEVOTEC NEUROSCIENCES GMBH11VON DER KAMMER HEINZ9HIPFEL RAINER3MAX PLANCK GESELLSCHAFT3TOPAS THERAPEUTICS GMBH3
Top patents by PatentIndex Score
45 records- 0183US5427927AProcess for the enzymatic cleavage of recombinant proteins using IgA proteasesMAX PLANCK GESELLSCHAFT·Filed 1991·Granted Jun 27, 1995·59 cites·57 claims
- 0277US12016931B2Nanoparticles comprising peptides including an n-terminal linkerTOPAS THERAPEUTICS GMBH·Filed 2023·Granted Jun 25, 2024·1 cites·30 claims
- 0360US2024293575A1Nanoparticles comprising peptides including an n-terminal linkerTOPAS THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0456US2006142194A1Methods and compounds for treating brain amyloidosisUNIV ZUERICH·Filed 2005·Application pending·0 cites
- 0551US2003143563A1Method for identifying a nucleic acidEVOTEC BIOSYSTEMS AG OF SCHNAC·Filed 2002·Application pending·0 cites
- 0647US2004038302A1Methods and compounds for treating brain amyloidosisFiled 2001·Application pending·0 cites
- 0746US2006259991A1Diagnostic and therapeutic use of scn2b protein for neurodegeneraative diseasesEVOTECH NEUROSCIENCES GMBH·Filed 2004·Application pending·0 cites
- 0843US6040141ABacteria for preparing stable fusion proteins and methods for detecting the sameMAX PLANCK GESELLSCHAFT·Filed 1994·Granted Mar 21, 2000·8 cites·24 claims
- 0943US2005153295A1Diagnostic and therapeutic use of human maguin proteins and nucleic acids for neurodegenerative diseasesFiled 2003·Application pending·0 cites
- 1042US2023087405A1Amphiphilic polymers and their use for improved production of nanoparticles for the targeted delivery of antigensTOPAS THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 1141US2006024305A1Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseasesHIPFEL RAINER·Filed 2003·Application pending·0 cites
- 1240US5268270AProcess for producing proteins using gram negative host cellsMAX PLANCK GESELLSCHAFT·Filed 1987·Granted Dec 7, 1993·7 cites·9 claims
- 1340US2006088827A1Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseasesHIPFEL RAINER·Filed 2003·Application pending·0 cites
- 1440US2007199080A1Diagnostic and therapeutic use of F-box proteins for Alzheimer's disease and related neurodegenerative disordersEVOTEC NEUROSCIENCES GMBH·Filed 2007·Application pending·0 cites
- 1540US2006259990A1Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2003·Application pending·0 cites
- 1640US2006099585A1Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseasesEVOCTEC NEUROSCIENCES GMBH·Filed 2003·Application pending·0 cites
- 1739US2006051757A1Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2003·Application pending·0 cites
- 1839US2006073480A1Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2003·Application pending·0 cites
- 1939US2006052280A1Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2003·Application pending·0 cites
- 2037US2009255003A1Diagnostic and therapeutic target SLC39A11 proteins for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2006·Application pending·0 cites
- 2137US2004241694A1Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disordersFiled 2002·Application pending·0 cites
- 2237US2004053265A1Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disordersFiled 2001·Application pending·0 cites
- 2337US2009172827A1Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseasesPOHLNER JOHANNES·Filed 2006·Application pending·0 cites
- 2436US2006223065A1Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseasesEVOTEC NEUROSCIENCE GMBH·Filed 2004·Application pending·0 cites
- 2534US2007186290A1Diagnostic and therapeutic use of the human hif3alpha gene and proteins for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2004·Application pending·0 cites
- 2634US2005214763A1Diagnostic and therapeutic use of an activator protein for vesicle secretion for neurodegenerative diseasesHIPFEL RAINER·Filed 2003·Application pending·0 cites
- 2732US2006160728A1Diagnostic and therapeutic use of ensandin-0138 gene and protein for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2003·Application pending·0 cites
- 2832US2007162983A1Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2004·Application pending·0 cites
- 2931US8114620B2Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseasesPOHLNER JOHANNES·Filed 2006·Granted Feb 14, 2012·0 cites·1 claims
- 3031US2004157225A1Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disordersFiled 2002·Application pending·0 cites
- 3131US2007118913A1Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseasesHESTERKAMP THOMAS·Filed 2003·Application pending·0 cites
- 3231US2009047274A1Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2006·Application pending·0 cites
- 3331US2009133135A1Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative DiseasesEVOTEC NEUROSCIENCES GMBH·Filed 2006·Application pending·0 cites
- 3430US6566062B1Method for identifying a nucleic acidEVOTEC BIOSYSTEMS AG·Filed 1998·Granted May 20, 2003·2 cites·19 claims
- 3530US2010008921A1Diagnostic and Therapeutic Target Adarb2 Proteins for Neurodegenerative DiseasesEVOTEC NEUROSCIENCES GMBH·Filed 2006·Application pending·0 cites
- 3630US2007269800A9Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseasesVON DER KAMMER HEINZ·Filed 2003·Application pending·0 cites
- 3730US2005289657A1Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseasesHESTERKAMP THOMAS·Filed 2003·Application pending·0 cites
- 3830US2007271619A1Diagnostic and Therapeutic Use of the Human Dax-1 Gene and Protein for Neurodegenerative DiseasesVON DER KAMMER HEINZ·Filed 2004·Application pending·0 cites
- 3929US2011010780A1Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2010·Application pending·0 cites
- 4029US2008269103A1Diagnostic and Therapeutic Use of the Kcne4 Gene and Protein for Alzheimer's DiseaseVON DER KAMMER HEINZ·Filed 2005·Application pending·0 cites
- 4129US2008038730A1Diagnostic and Therapeutic Use of Kcnj6 for Alzheimer's DiseaseVON DER KAMMER HEINZ·Filed 2005·Application pending·0 cites
- 4228US2008301821A1Diagnostic and Therapeutic use of a Plasma Membrane AtpaseEVOTEC NEUROSCIENCES GMBH·Filed 2005·Application pending·0 cites
- 4328US2007166718A1Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseasesEVOTEC NEUROSCIENCES GMBH·Filed 2005·Application pending·0 cites
- 4428US2008051334A1Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative DiseasesEVOTEC NEUROSCIENCES GMBH·Filed 2005·Application pending·0 cites
- 4524US6255097B1Two-phase system for the production and presentation of foreign antigens in hybrid live vaccinesMAX PLANCK GES ZU FORDERUNG DE·Filed 1991·Granted Jul 3, 2001·5 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Johannes Pohlner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →